Kari Natunen

930 total citations
19 papers, 403 citations indexed

About

Kari Natunen is a scholar working on Epidemiology, Surgery and Health. According to data from OpenAlex, Kari Natunen has authored 19 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 6 papers in Surgery and 4 papers in Health. Recurrent topics in Kari Natunen's work include Cervical Cancer and HPV Research (16 papers), Hepatitis B Virus Studies (13 papers) and Genital Health and Disease (4 papers). Kari Natunen is often cited by papers focused on Cervical Cancer and HPV Research (16 papers), Hepatitis B Virus Studies (13 papers) and Genital Health and Disease (4 papers). Kari Natunen collaborates with scholars based in Finland, Sweden and United States. Kari Natunen's co-authors include Matti Lehtinen, Tiina Eriksson, Dan Apter, Jorma Paavonen, ­Eero Pukkala, Gary Dubin, Joakim Dillner, Tapio Luostarinen, Frank Struyf and Johanna Palmroth and has published in prestigious journals such as The Journal of Infectious Diseases, International Journal of Cancer and Vaccine.

In The Last Decade

Kari Natunen

19 papers receiving 395 citations

Peers

Kari Natunen
Corinne Willame Belgium
Lisa Rambout Canada
F. Boselli Italy
Carlo Antonio Liverani Italy
Myriam Chévarie‐Davis Canada
Jacqueline Guidry United States
Päivi Laukkanen Finland
Ugyen Tshomo France
K. McNamee United Kingdom
Corinne Willame Belgium
Kari Natunen
Citations per year, relative to Kari Natunen Kari Natunen (= 1×) peers Corinne Willame

Countries citing papers authored by Kari Natunen

Since Specialization
Citations

This map shows the geographic impact of Kari Natunen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Natunen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Natunen more than expected).

Fields of papers citing papers by Kari Natunen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Natunen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Natunen. The network helps show where Kari Natunen may publish in the future.

Co-authorship network of co-authors of Kari Natunen

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Natunen. A scholar is included among the top collaborators of Kari Natunen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Natunen. Kari Natunen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nevalainen, Jaakko, Jani Raitanen, Kari Natunen, et al.. (2024). Early detection of clinically significant prostate cancer: protocol summary and statistical analysis plan for the ProScreen randomised trial. BMJ Open. 14(1). e075595–e075595. 1 indexed citations
2.
Rannikko, Antti, Tuomas Mirtti, Teemu Tolonen, et al.. (2021). Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study. British Journal of Urology. 130(2). 193–199. 12 indexed citations
3.
Lehtinen, Matti, Dan Apter, Tiina Eriksson, et al.. (2021). Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland. Cancer Medicine. 10(21). 7759–7771. 3 indexed citations
4.
Vänskä, Simopekka, Tapio Luostarinen, Iacopo Baussano, et al.. (2020). Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied. The Journal of Infectious Diseases. 222(6). 948–956. 37 indexed citations
5.
Kilpeläinen, Tuomas P., Kimmo Taari, Teuvo L.J. Tammela, et al.. (2020). Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study. Cancer Imaging. 20(1). 72–72. 13 indexed citations
6.
Lehtinen, Matti, Dan Apter, Tiina Eriksson, et al.. (2019). Effectiveness of the AS04‐adjuvanted HPV‐16/18 vaccine in reducing oropharyngeal HPV infections in young females—Results from a community‐randomized trial. International Journal of Cancer. 147(1). 170–174. 18 indexed citations
7.
8.
Palmroth, Johanna, Tapio Luostarinen, Dan Apter, et al.. (2018). Evaluation of HPV type‐replacement in unvaccinated and vaccinated adolescent females—Post‐hoc analysis of a community‐randomized clinical trial (II). International Journal of Cancer. 142(12). 2491–2500. 30 indexed citations
9.
Söderlund‐Strand, Anna, Tiina Petäjä, Tiina Eriksson, et al.. (2017). Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16/18 Vaccination. The Journal of Infectious Diseases. 216(8). 966–968. 9 indexed citations
10.
Lehtinen, Matti, Heljä‐Marja Surcel, Kari Natunen, ­Eero Pukkala, & Joakim Dillner. (2017). Cancer Registry follow‐up for 17 million person‐years of a nationwide maternity cohort. Cancer Medicine. 6(12). 3060–3064. 22 indexed citations
11.
Lehtinen, Matti, Camilla Lagheden, Tapio Luostarinen, et al.. (2017). Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials. BMJ Open. 7(8). e015867–e015867. 72 indexed citations
12.
Lehtinen, Matti, Tiina Eriksson, Dan Apter, et al.. (2016). Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial. Human Vaccines & Immunotherapeutics. 12(12). 3177–3185. 22 indexed citations
13.
Lehtinen, Matti, Dan Apter, Iacopo Baussano, et al.. (2015). Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial. Vaccine. 33(10). 1284–1290. 39 indexed citations
14.
15.
Palmroth, Johanna, Marko Merikukka, Jorma Paavonen, et al.. (2012). Occurrence of vaccine and non‐vaccine human papillomavirus types in adolescent Finnish females 4 years post‐vaccination. International Journal of Cancer. 131(12). 2832–2838. 25 indexed citations
16.
Huhtala, Heini, Dan Apter, Tiina Eriksson, et al.. (2012). Understanding long‐term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry‐based follow‐up. International Journal of Cancer. 132(12). 2833–2838. 36 indexed citations
17.
Malmqvist, Erik, Kari Natunen, Matti Lehtinen, & Gert Helgesson. (2011). Just implementation of human papillomavirus vaccination. Journal of Medical Ethics. 38(4). 247–249. 13 indexed citations
18.
Natunen, Kari, et al.. (2011). Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries. Infectious Diseases in Obstetrics and Gynecology. 2011. 1–10. 17 indexed citations
19.
Malmqvist, Erik, et al.. (2010). The ethics of implementing human papillomavirus vaccination in developed countries. Medicine Health Care and Philosophy. 14(1). 19–27. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corinne Willame Breakdown of academic impact, for papers by Lisa Rambout Breakdown of academic impact, for papers by F. Boselli Breakdown of academic impact, for papers by Carlo Antonio Liverani Breakdown of academic impact, for papers by Myriam Chévarie‐Davis Breakdown of academic impact, for papers by Jacqueline Guidry Breakdown of academic impact, for papers by Päivi Laukkanen Breakdown of academic impact, for papers by Ugyen Tshomo Breakdown of academic impact, for papers by K. McNamee
Rankless by CCL
2026